Latest Information Update: 18 Nov 2003
At a glance
- Originator Bioglan Pharma [CEASED]
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetic foot ulcer
Most Recent Events
- 14 Sep 2001 Phase-II clinical trials for Diabetic foot ulcer in USA (Unknown route)